Mary Dean Hall - 19 Apr 2021 Form 4/A - Amendment Insider Report for Ingevity Corp (NGVT)

Role
EVP, Chief Financial Officer
Signature
/s/ Mary Dean Hall By: Stacy L. Cozad as Attorney-in-Fact
Issuer symbol
NGVT
Transactions as of
19 Apr 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
17 Dec 2021, 20:14:08 UTC
Date Of Original Report
20 Apr 2021
Next filing
26 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGVT Employee Stock Option (right-to-buy) Award $0 +2,519 $0.000000 2,519 19 Apr 2021 Common Stock 2,519 $73.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's Form 4 filed with the SEC on April 20, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). This amendment is being filed solely to correct the exercise price.
F2 These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning April 19, 2022, 2023 and 2024.